Menu
TRI News
"Shifting the dial"
New TRI CEO Professor Maher Gandhi has outlined ambitions for in-house clinical trials, translational manufacturing and working with industry.
He has taken up his new role this month, saying it is a marvellous opportunity to work with our partners to build something that is greater than the sum of its parts.
Filter by
Research area